Genome study links DNA changes to the risks of specific breast cancer subtypes


DNA
DNA double helix. Credit: public domain

An analysis of genetic studies covering 266,000 women has revealed 32 new sites on the human genome where variations in DNA appear to alter the risks of getting breast cancer. The study lead and senior authors included researchers at Johns Hopkins Bloomberg School of Public Health. The findings are thought to be the first to link such risk variants to multiple, detailed subtypes of breast cancer.

The new analysis, published May 18 in Nature Genetics, made use of data gathered by the Cambridge, UK-based Breast Cancer Association Consortium from more than 100 breast studies conducted over the past 15 years, mostly among women of European ancestry. The analysis included new methods allowing the identification of DNA variants that have heterogeneous effects across subtypes, such as Luminal-A and triple negative, which can be defined by various tumor characteristics.

The research was conducted in collaboration with investigators across a large number of institutions, including the National Cancer Institute in the U.S., Harvard University’s T. H. Chan School of Public Health, Cambridge University, and Netherlands Cancer Institute.

Prior genetic studies in this field have analyzed only the risks of breast cancer generally, or of relatively simple sets of subtypes such as estrogen receptor-positive versus estrogen receptor-negative breast cancers. Assessing breast cancer subtype risk more comprehensively has long been a goal of cancer researchers, because these subtypes—which include the aggressive triple-negative and BRCA1 subtypes—often vary tremendously in the long-term risks they pose to the life and health of patients.

“The findings from this analysis enhance our understanding of the biology that differentiates subtypes and may improve our ability to predict women’s breast cancer risks, even at the level of specific breast cancer subtype,” says Nilanjan Chatterjee, Ph.D., Bloomberg Distinguished Professor in the Department of Biostatistics at the Bloomberg School and the paper’s corresponding author.

Each year more than 250,000 women in the United States are diagnosed with breast cancers, and more than 40,000 die of them. Prior to the new analysis, researchers had identified, across the genome, more than 170 gene variants or other DNA variants that appear to raise—or in some cases, lower—the risks of getting these cancers.

“Each one of these variants has a small apparent effect on breast cancer risk, and there may be a substantial effect when a person has a combination of them,” Chatterjee says.

Researchers have sought to identify these as comprehensively as possible, so that women can be informed in advance about their likely chances of developing breast cancer, and can be screened for cancer more frequently should their risk seem high.

To that end, the new analysis reviewed one of the largest-ever sets of data from breast cancer genetic studies. It also involved the application of new tools to link DNA variants to specific breast cancer subtypes, defined for example by the presence of different receptors on the cancer cells’ surface, by the cancer “grade”—a low/intermediate/high metric of the tumor’s potential to spread—and by common combinations of such factors.

In all, the analysis identified 32 new risk variants for breast cancer generally. Of these, 15 variants were also linked independently to one or more specific breast cancer subtypes. Seven of the 15 were linked to estrogen receptor status, seven to the tumor grade, four to HER2 receptor status and two to progesterone receptor status.

The findings help expand scientific understanding of the genetic architecture of breast cancer, and in principle allow oncologists to now calculate more accurate, potentially subtype-specific, risk scores for women based on the combinations of variants they have.

The research may also lead to new discoveries about the underlying biological pathways that drive cancer. Scientists can follow up the new findings by exploring how each risk-linked DNA variation—some within known genes, others in stretches of DNA that have no known function—affects gene activity and signaling networks in cells.

Of note, five of the newly discovered subtype-specific risk variants are linked to a greater risk of some breast cancer subtypes but a lower risk of others.

“These variants are special and if followed up properly may lead to important insights into the biology of these cancer subtypes,” Chatterjee says.

He and his colleagues now hope to confirm and expand their findings in future analyses covering larger, more ethnically diverse populations of patients.


Black/white breast cancer subtype incidence in men differs from trends in women


More information:
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses, Nature Genetics (2020). DOI: 10.1038/s41588-020-0609-2 , www.nature.com/articles/s41588-020-0609-2

Citation:
Genome study links DNA changes to the risks of specific breast cancer subtypes (2020, May 18)
retrieved 19 May 2020
from https://medicalxpress.com/news/2020-05-genome-links-dna-specific-breast.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



loading...

Related posts:

Similar to adults, obesity raises kids' odds for severe COVID-19
Germany to lift travel warning for Europe from June 15
Weight, blood pressure higher in younger patients with T2DM
Reducing number of BP meds may be safe in some older adults
At-home gene test for breast, ovarian cancers looks effective
People are avoiding the ER during COVID-19 crisis at their peril: study
In a first, researchers use base editing to correct recessive genetic deafness and restore partial h...
Engineered T cells for type 1 diabetes move closer to clinic
Cardiologist investigates why TAVR might not work for some heart patient
Metaanalyse: Monotherapie der Onychomykose - Biermann Medizin
Belgium to reopen borders with neighbours on June 15
DDG: Ernährungsreport des BMEL ignoriert Ausmaß der Fehlernährung
Cholesterol levels dropping in Western nations—but rising in Asia
Studie: Aussagen zur Ansteckungsgefahr durch Kinder bleiben bestehen
how physicians used it 500 years ago to control the bubonic plague
Uniklinik Ulm bietet nun Fertilitätsbehandlugnen mit Samenspende an
Remote devices for telehealth see surge in demand
Wundheilung detailliert aufgeschlüsselt - Biermann Medizin
Diet, gut microbes affect effectiveness of cancer treatment, research reveals
Forschung abseits von COVID-19: Kommen Krebsmedizin und Co. nun zu kurz?
Helping unlock personalised interventions for kids with developmental disabilities
Diamanttechnik im Herzkatheterlabor - Biermann Medizin
Benzodiazepine use before conception is linked to increased risk of ectopic pregnancy
Verbesserte Wundheilung mit thrombozytenreichem Plasma
Method to identify neural inputs that convey information for defined behaviors
Virchowbund: Die richtigen Lehren aus Corona ziehen
UK mulls 'air bridges' with low-risk countries
3-D-Gebärdensprach-Avatar - Biermann Medizin
A satisfying romantic relationship may improve breast cancer survivors' health
UKE-Studie untersucht Folgen der Corona-Pandemie für die psychische Gesundheit von Kindern
Families and communities are central to the recovery of Sierra Leone's former child soldiers
KMT-Patienten: Sichere Augenversorgung in der Corona-Krise
Expression of certain genes may affect vulnerability to post-traumatic stress disorder
Corona-Pandemie verschlechtert wirtschaftliche Lage der Krankenhäuser
Negative emotions cause stronger appetite responses in emotional eaters
Final states reopen amid worries that protests will spark new COVID infections
Scientists find a switch to flip and turn off breast cancer growth and metastasis
Impact of COVID-19 infection in blood cancer patients
Study in twins finds our sensitivity is partly in our genes
NIH funded research related to every new cancer drug approved from 2010-2016, totals $64B
Social status helped and hindered by the same behaviors and traits worldwide
Concerns mount about two studies on drugs for coronavirus
New CRISPR advance may solve key quandary
Spain records no virus deaths for second day running
Kölner Forschungsprojekt gestartet: COVID-19-Krise aus Sicht des ambulanten Sektors
Understanding the role of cardiorespiratory fitness and body composition in brain health
Neue Nachwuchsgruppe „Zellbiologie der RNA-Viren“ am HPI
Maria shriver and AARP take on Alzheimer's in women
Viel weniger Schlaganfall- und Herzinfarktpatienten in Notaufnahmen
Rolling lockdowns could protect both economies and health in low-income countries
Neue Leitung der Allgemein- und Viszeralchirurgie am Klinikum Kassel
Lab-grown miniature human livers successfully transplanted in rats
Mehr Lebertransplantationen im ersten Quartal
Facts and myths about obesity, emerging as a key factor in COVID-19 hospitalization
Jagd auf lebensbedrohliche Metastasen - Biermann Medizin
Where are kids getting the most 'empty calories'?
Handhygiene: Zunahme von Handekzemen - Biermann Medizin
Tauvid receives approval for tau pathology imaging
COVID-19: Reproduktionszahl genauer geschätzt - Biermann Medizin
You don't smoke, but your home could have thirdhand smoke residue
Evolutionäre Rätsel Säugetierohr - Biermann Medizin
Back to school in masks as Singapore eases virus curbs
Welche Rolle spielen B-Zellen bei kardiovaskulären Erkrankungen?
Pandemic antibiotics surge will cause more deaths: WHO
Studie: Sterberisiko nach Operationen bei Corona-Infizierten erhöht
Lockdowns ease in Florida, Europe with new tourism rules
Reduced humidity linked to increased COVID-19 risk
Glaukomentstehung: Welche Rolle spielt die körpereigene Immunabwehr?
Resistance to immunosurveillance favors cluster cancer metastasis
ADHS: Gleichstromstimulation zeigt klinische Wirkung
Study examines how Americans are coping with COVID-19 stress
Rheumaerkrankungen in der Corona-Situation - Biermann Medizin
Warmer temperatures slow COVID-19 transmission, but not by much
Virus still potent says WHO, after claim by Italian doctor
Engineers design nanoparticles that stimulate the immune system, helping it to attack tumors
Genetic cause of difference in sexual development uncovered
For each day's delay in social distancing, a COVID-19 outbreak lasts days longer
Evidence supports physical distancing, masks, and eye protection to help prevent COVID-19
Study seeks to optimize comfort for patients removed from ventilators at end of life
Europe loosens lockdown as virus tightens grip on Americas
Your brain needs to be ready to remember?
Italy records fewest new virus cases since February
Most Americans still more worried about COVID-19 spread than the economy
Britain takes its biggest step yet out of lockdown
Obesity a major risk factor for COVID-19 hospitalization
Pathogen scientist collaborating on vaccine that could prevent and treat COVID-19
Scientists develop means for detecting early stages of lung problems caused by COVID-19
UTSA software helps patients receive faster post-pandemic care
Almost 6 in 10 Aussies living in aged care are in inadequately staffed facilities
North Korea to reopen schools as virus fears ease
Moscow eases lockdown despite high virus caseload
Hauchdünne Fasern sollen Nerven nach Hirn-OP schützen
Debates rage in Britain as some children go back to school
Mögliches Referenzmessverfahren für die Analyse auf SARS-CoV-2
Putzfimmel im Gehirn - Biermann Medizin
Arbeitsbedingungen in der Intensivpflege prekärer denn je – DGIIN veröffentlicht Stellungnahme
US records 1,225 coronavirus deaths in 24 hours: Johns Hopkins
Coronavirus hopes and fears center on 'immunity'
Assessing cancer diagnosis in children with birth defects
Public health campaigns can do better on cannabis harm reduction

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Naser Ramadani sot do e njoftojë Komisionin për Shëndetësi

Tue May 19 , 2020
Drejtori i IKSHPK-së, Naser Ramadani, sot do e njoftojë Komisionin për Shëndetësinë për situatën e pandemisë. Anëtarët e Komisionit për Shëndetësi dhe Mirëqenie Sociale sot do të takojnë drejtorin e Institutit Kombëtar të Shëndetësisë Publike të Kosovës, Naser Ramadani dhe drejtorin e Qendrës Klinike Universitare të Kosovës, Basri Sejdiu. Related […]
Ramadani: Ende nuk ka kaluar pandemia, duhet të kemi kujdes